About McKesson
McKesson is a publicly listed company based in Irving (United States) founded in 1833. Products and services are provided in the healthcare industry. It operates on a Reseller / Distribution and Managed Services model. The company has 45,000 employees. McKesson has completed 29 acquisitions, including Biologics, Fitness2live and GMD PharmaSolutions. Its chief executive, as recorded, is Brian S Tyler. Its website mckesson.com draws about 4.3 million monthly visits. McKesson offers products and services including Pharmaceutical Distribution Services, Medical Supply Distribution, Oncology & Multispecialty Solutions, and Prescription Benefit Solutions. Its focus areas include Healthcare Services, Distribution Services, Healthcare Technology and Health IT Solutions. Its legal entity is McKesson Corporation. Its competitors include Resilience and PAR Excellence; 1 of its 2 listed competitors has raised funding.
Company details
McKesson is involved in the distribution of pharmaceuticals and medical supplies across North America, serving pharmacies, hospitals, and clinics. Various healthcare solutions are provided, including oncology and multispecialty support, prescription benefit solutions, and biopharma capabilities. The company is focused on improving care through innovative technologies and partnerships within the healthcare ecosystem. Operations are extended to address access, affordability, and adherence challenges in the sector.
- Headquarters Irving, United States
- Employees 45,000
- Stage Public
- SectorsHealthcare
- Website category Health
- Email••••••••
- Phone•••• ••••
- Website mckesson.com
- Social LinkedIn X Facebook Instagram
- Legal Name Mckesson Corporation
- Annual Revenue$403.43 B (USD)12.36as on Mar 31, 2026
- Net Profit$4.76 B (USD)44.52as on Mar 31, 2026
- EBITDA$6.68 B (USD)33.39as on Mar 31, 2026
- Latest Funding Round$4B (USD), Debt – Conventional
Oct 2019
- Employee Count45,000
- Investments & AcquisitionsBiologics
& 28 more
Products & Services of McKesson
McKesson offers a comprehensive portfolio of products and services, including Pharmaceutical Distribution Services, Medical Supply Distribution, Oncology & Multispecialty Solutions, and Prescription Benefit Solutions.
Pharmaceuticals are distributed to various healthcare settings efficiently.
Medical supplies are provided to healthcare facilities across regions.
Support is offered for cancer and specialty care challenges.
Lower-cost prescription options are provided to various stakeholders.
Funding Insights of McKesson
- Total Rounds 1
- Last Round Debt – Conventional — $4B
- First Round $4B
(Oct 2019)
All 1 funding rounds of McKesson with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $4B | Debt – Conventional | – | – | – |
People of McKesson
981 people are tracked at McKesson (460 in leadership, 7 in board & advisors, 514 in team); the tracked headcount is 45,000.
| Name | Role | Group |
|---|---|---|
Brian S Tyler | CEO | Leadership |
Katya Hall | MHS Segment Cio, Head Of Customer Reporting & Analytics | Leadership |
Diamara Desouza | Senior Director Human Resources | Leadership |
Bilal Zuberi | Senior Director Of Customer Analytics & Reporting Services | Leadership |
Jay Hoage | Director Of Franchise Administration | Leadership |
Brogan Wolfe | Director | Leadership |
Sarah Pate | Sr. Director Trade Accounts Payable | Leadership |
Stephen Bankston | Director | Leadership |
Darlene Ray | RNA Support Solutions-director Of Operations | Leadership |
Cameron Roberts | Assistant Director Of Operations | Leadership |
Gary Miller | Corporate Account Director | Leadership |
Farhad Sayeed | Sr. Director Engineering & Operations | Leadership |
Jennifer Serkins-Pate | Vice President Of Sales | Leadership |
Joseph Carrero | Vice President, Sales | Leadership |
Joe Chisholm | Senior Director, Category Profitability Improvement, Mckesson Medical-surgical | Leadership |
Donncha MacLaifeartaigh | Director Of Business Development | Leadership |
Linda Brozell | Director Partnerships & Vendor Relations, Commercial Strategy & Innovation | Leadership |
Bill Trotter | Director, Decision Intelligence | Leadership |
Mike Cihlar | National Vp, Pharmacy Retail Operations | Leadership |
Amanda Bounds | Sr. Director - Contract Administration | Leadership |
961 more people are available in the full profile.
Complete people profiles for McKesson
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of McKesson
McKesson is a publicly listed company on the NYSE with ticker symbol MCK in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Aug 1987
- Listed onNYSE: MCK
- Listed entityMcKesson Corporation
- Exchange sectorDistribution services
- ISINUS58155Q1031
- Share price$961.88 (+0.64% on the day) · 2026-10-13
- Market capitalisation$112.15B
- Price to earnings25.7
- EPS (diluted, trailing year)$37.37
- Dividend yield0.35%
- Volume (last session)743,641
Financials of McKesson
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $403.43B | $4.76B | $6.68B |
| 2024 | $359.05B | $3.29B | $5.01B |
| 2023 | $308.95B | $3.00B | $4.56B |
| 2022 | $276.71B | $3.56B | $5.31B |
| 2021 | $263.97B | $1.11B | $3.72B |
Detailed financial statements for McKesson
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by McKesson
McKesson has strategically engaged in corporate development activities, having acquired 29 companies. Notable acquisitions include Biologics, Fitness2live and GMD PharmaSolutions.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of administrative services to ophthalmology practices. It supports practices in delivering eye care services and creates a positive work environment for affiliated physicians and employees. The organization offers services to help practices improve efficiency and focus on patient care. This includes support for business operations, allowing physicians to concentrate on clinical work. A physician-led organization, it values input from its physician leaders in guiding the direction and growth of the enterprise. | prismvisiongroup.com | Union, United States | 2008 | Feb 2025 | $850M | |
Cloud-based pharmacy benefits management platform for employees | rxss.com | Overland Park, United States | 2004 | Sep 2022 | •••• | |
OncoHealth is focused on delivering oncology-focused digital health solutions. | oncohealth.us | Atlanta, United States | 2009 | May 2022 | •••• | |
Medicines optimisation, pharmacist support, and clinical services are provided. | prescribingsupportservices.co.uk | Shipley, United Kingdom | 2000 | Dec 2018 | •••• | |
Distributor of infusion related products and biomedical equipment | msdonline.com | Stoughton, United States | 2005 | Apr 2018 | •••• | |
Turnkey healthcare solutions are provided to physicians by management firm. | intrafusion.com | Houston, United States | 1999 | Jul 2017 | •••• | |
Pharmaceutical distribution and management services are provided in Canada. | gmdpharma.ca | Oakville, Canada | 2004 | Feb 2017 | •••• | |
Value-based payment analytics are provided for health plans and systems. | healthqx.com | King Of Prussia, United States | 2012 | Jul 2016 | •••• | |
Healthcare services and pharmacy products are provided across Canada. | rexall.ca | Mississauga, Canada | 1904 | Mar 2016 | $2.14B | |
Provider of radiation oncology, medical oncology and other value-based integrated cancer care services | vantageoncology.com | Manhattan Beach, United States | 2002 | Feb 2016 | •••• |
Complete acquisition details for McKesson
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of McKesson
13 dated milestones of McKesson across 192 years, from founding to its latest funding, stage changes and deals.
- Founded McKesson is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Vantage Oncology.
- Acquisition Acquires Rexall.
- Acquisition Acquires HealthQx.
- Acquisition Acquires GMD PharmaSolutions.
- Acquisition Acquires intraFUSION.
- Acquisition Acquires Medical Specialties Distributors.
- Acquisition Acquires Prescribing Support Services.
- Funding First funding round of $4.0B.
- Acquisition Acquires OncoHealth.
- Acquisition Acquires Rx Savings Solutions.
- Acquisition Acquires Prism Vision Group.
Competitors of McKesson
McKesson has 2 listed competitors in our database, 1 of them funded. They include Resilience and PAR Excellence.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| resilience.com | 1995 | San Diego, United States | $1.99B | Supply chain services for biopharma sector are provided. | ||
| parexcellence.com | 1997 | Cincinnati, United States | Supply chain logistics services are provided for the biopharma sector. |
Detailed competitors of McKesson
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of McKesson
The website of McKesson (mckesson.com) receives about 4.3M visits a month and ranks #12,546 among all websites worldwide, #244 in Health.
- Monthly visits4.3M
▲ 2.9% vs previous month
- Unique visitors556.1K
per month
- Global rank#12,546
among all websites
- Category rank#244
Health · Health
- Bounce rate24%
- Pages per visit5.8
- Average visit5 min 36 sec
- DevicesDesktop 92% · Mobile 8%
Websites whose visitors overlap most with McKesson. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medline.com | 100% | 2M | #21,342 | View details | |
| henryschein.com | 92% | 811.3K | #55,343 | View details | |
| cardinalhealth.com | 89% | 2.3M | #23,465 | View details | |
brightree.net | brightree.net | 84% | #11,687 | – | |
mckessoncorp-my.sharepoint.com | mckessoncorp-my.sharepoint.com | 83% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for McKesson
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as McKesson (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mckesson
Complete news archive for McKesson
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about McKesson
McKesson was founded in 1833 and raised its 1st funding round 186 years after it was founded.
McKesson is headquartered in Irving, United States. It is registered at Irving, Texas, United States.
Brian S Tyler is the CEO of McKesson, as recorded in our data.
McKesson has 45,000 employees.
Annual revenue of McKesson is $403.43B as on Mar 31, 2026.
McKesson is involved in the distribution of pharmaceuticals and medical supplies across North America, serving pharmacies, hospitals, and clinics. Various healthcare solutions are provided, including oncology and multispecialty support, prescription benefit solutions, and biopharma capabilities. The company is focused on improving care through innovative technologies and partnerships within the healthcare ecosystem. Operations are extended to address access, affordability, and adherence challenges in the sector.
McKesson's top competitors include Resilience and PAR Excellence.
McKesson offers Pharmaceutical Distribution Services, Medical Supply Distribution, Oncology & Multispecialty Solutions, and Prescription Benefit Solutions.
Yes, McKesson is publicly traded on NYSE under the ticker symbol MCK.
McKesson has made 29 acquisitions, including Biologics, Fitness2live, and GMD PharmaSolutions.
McKesson operates through Mckesson Corporation.
The website of McKesson receives about 4.3 million visits a month and ranks #12,546 among all websites worldwide.